Find Federal Grants
Washington Headquarters Services · HQ003422NFOEASD01
Rehabilitation Engineering Research Centers (RERC) Program: RERC on Rehabilitation Strategies, Techniques, and Interventions
Administration for Community Living · HHS-2022-ACL-NIDILRR-REGE-0024
FY22 Department of Navy (DON) Science, Technology, Engineering & Mathematics (STEM), Education and Workforce Program administered by the Office of Naval Research (ONR)
Office of Naval Research · N00014-22-S-F003
Real-Time Assessment and Augmentation of Cognitive Performance in Extreme Environments
Air Force -- Research Lab · FA8650-22-S-5006
U.S. Mission to France · PDS-FRANCE-FY2022-03
Disability and Rehabilitation Research Projects (DRRP) Program: Americans With Disabilities Act (ADA) National Network Collaborative Research Project
Administration for Community Living · HHS-2022-ACL-NIDILRR-DPAD-0036
FY 2022 NOAA SBIR Phase II
Department of Commerce · NOAA-OAR-OAR-TPO-2022-2007174
Dept of the Army -- Materiel Command · W911NF-22-S-0006
Dept of the Army -- Materiel Command · W911NF-22-S-0005
Office of Science · DE-FOA-0002635
Naval Supply Systems Command · N00244-22-S-NPS-F001
In Vitro Based Approaches to Evaluate the Bioequivalence of Generic Rectal and Vaginal Products
Food and Drug Administration · RFA-FD-22-014
Deconstruction of data and standards to support harmonization and interoperability with real world data for clinical research and regulatory submissions. (U01 Clinical Trial Not Allowed)
Food and Drug Administration · RFA-FD-22-022
Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional
Food and Drug Administration · RFA-FD-22-016
In Vitro Approaches to Evaluate and Compare the Adhesion Performance of Transdermal and Topical Delivery Systems (TDS) (U01) Clinical Trial Required
Food and Drug Administration · RFA-FD-22-015
Development of advanced analytical methods for the characterization of complex generics
Food and Drug Administration · RFA-FD-22-013
PBPK modeling to support assessment of bioequivalence of locally acting drugs in the gastrointestinal tract
Food and Drug Administration · RFA-FD-22-012
Investigating the in vivo behavior and in vitro characteristics purportedly gastro-retentive extended release formulation to enhance the regulatory standard of such products
Food and Drug Administration · RFA-FD-22-018
Cutaneous pharamcokinetic-based approaches to establish bioequivalence of topically applied drug products
Food and Drug Administration · RFA-FD-22-017
Cooperative Agreement for CESU-affiliated Partner with Rocky Mountains Cooperative Ecosystem Studies Unit
Geological Survey · G22AS00124